HAS
AVXL icon

HBW Advisory Services’s Anavex Life Sciences AVXL Stock Holding History

HBW Advisory Services’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,016
Closed -$43K – 466
2026
Q1 		$43K Buy
14,016
+2,877
+26% +$12.5K ﹤0.01% 441
2025
Q4 		$39.7K Buy
+11,139
New +$68.2K ﹤0.01% 417

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBW Advisory Services's AVXL Position: Q2 2026 in Review

HBW Advisory Services sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 14,016 shares — an estimated $43K sold.

HBW Advisory Services first reported a position in AVXL in Q4 2025 and held it in 2 quarters. The position peaked at $43K in Q1 2026. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • HBW Advisory Services reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • HBW Advisory Services sold 14,016 Anavex Life Sciences shares in Q2 2026, an estimated $43K.
  • HBW Advisory Services first reported a position in Anavex Life Sciences in Q4 2025 and held it in 2 quarters.
  • HBW Advisory Services's Anavex Life Sciences position peaked at $43K in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on HBW Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.